English

Immunotech Laboratories, Inc.

EDGAR

Annual report (10-K) · filed 2011-01-05

34 filing records in this dataset, filed from 2001-11-14 to 2011-01-05. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2004-09-30 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Cash and cash equivalents: 306 USD 2004-09-30 Source
Exact value

306 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Capital expenditure

0 USD

2003-10-01 – 2004-09-30

Exact inputs and evidence

Capital expenditure: 0 USD · 2003-01-01 – 2003-12-31 Source
Capital expenditure: 0 USD · 2003-01-01 – 2003-09-30 Source
Capital expenditure: 0 USD · 2004-01-01 – 2004-03-31 Source
Capital expenditure: 0 USD · 2004-01-01 – 2004-06-30 Source
Capital expenditure: 0 USD · 2004-01-01 – 2004-03-31 Source
Capital expenditure: 0 USD · 2004-01-01 – 2004-09-30 Source
Capital expenditure: 0 USD · 2004-01-01 – 2004-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2011-01-05.

Financial data available through: 2009-12-31.

Coverage by financial measure

Revenue: 4 of 11 periods available· newest 2009-12-31
Operating income: 1 of 11 periods available· newest 2009-12-31
Net income: 4 of 11 periods available· newest 2009-12-31
Operating cash flow: 3 of 11 periods available· newest 2003-12-31
Capital expenditure: 3 of 11 periods available· newest 2003-12-31
Total assets: 3 of 11 periods available· newest 2003-12-31
Total liabilities: 3 of 11 periods available· newest 2003-12-31
Current assets: 3 of 11 periods available· newest 2003-12-31
Current liabilities: 2 of 11 periods available· newest 2003-12-31
Cash and cash equivalents: 3 of 11 periods available· newest 2003-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

No unambiguous prior-year comparison is available for the latest reporting period.

Comparable inputs unavailable for: Revenue, Net income, Operating cash flow, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2009 2009-01-01 – 2009-12-31

Revenue USD 0
Operating costs Derived USD 958,935
Operating income −USD 958,935
Tax, interest and other Derived USD 18,635
Net income −USD 977,570

Cash

Operating cash flow Unavailable An input is unavailable.
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2001 Not shown: operating income or net income is not reported.
2002 Not shown: operating income or net income is not reported.
2003 Not shown: operating income or net income is not reported.
2009 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2001 2001-01-01 – 2001-12-31	0	Unavailable	Unavailable	Unavailable	-753663	-119132 Derived	Source 2001-01-01 – 2001-12-31: 0 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -753663 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: -109930 USD Inspect Operating Cash Flow Open source 2001-01-01 – 2001-12-31: 9202 USD Inspect Capital Expenditure Open source
2002 2002-01-01 – 2002-12-31	0	Unavailable	Unavailable	Unavailable	-1545125	-510762 Derived	Source 2002-01-01 – 2002-12-31: 0 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -1545125 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: -483294 USD Inspect Operating Cash Flow Open source 2002-01-01 – 2002-12-31: 27468 USD Inspect Capital Expenditure Open source
2003 2003-01-01 – 2003-12-31	360000	Unavailable	Unavailable	Unavailable	-314597	-63137 Derived	Source 2003-01-01 – 2003-12-31: 360000 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -314597 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -63137 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 0 USD Inspect Capital Expenditure Open source
2009 2009-01-01 – 2009-12-31	0	958935 Derived	-958935	18635 Derived	-977570	Unavailable	Source 2009-01-01 – 2009-12-31: 0 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: -958935 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: -977570 USD Inspect Net Income Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 2009

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20012001-12-31	Revenue	0	Revenue: 0 Open source
20022002-12-31	Revenue	0	Revenue: 0 Open source
20032003-12-31	Revenue	360000	Revenue: 360000 Open source
20092009-12-31	Revenue	0	Revenue: 0 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20012001-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
20022002-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20032003-12-31	Year over year	No prior comparable period	Revenue: 360000 Open source Revenue: 0 Open source
20092009-12-31	Year over year	No prior comparable period	Revenue: 0 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Net margin -87.4% 2003

Free cash flow margin -17.5% 2003

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
2001-12-31	Operating margin	Not reported	Revenue: 0 Open source
2002-12-31	Operating margin	Not reported	Revenue: 0 Open source
2003-12-31	Operating margin	Not reported	Revenue: 360000 Open source
20092009-12-31	Operating margin	Not reported	Operating Income: -958935 Open source Revenue: 0 Open source
20012001-12-31	Net margin	Not reported	Net Income: -753663 Open source Revenue: 0 Open source
20022002-12-31	Net margin	Not reported	Net Income: -1545125 Open source Revenue: 0 Open source
20032003-12-31	Net margin	-87.4%	Net Income: -314597 Open source Revenue: 360000 Open source
20092009-12-31	Net margin	Not reported	Net Income: -977570 Open source Revenue: 0 Open source
20012001-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -109930 Open source Capital Expenditure: 9202 Open source
20022002-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -483294 Open source Capital Expenditure: 27468 Open source
20032003-12-31	Free cash flow margin	-17.5%	Revenue: 360000 Open source Operating Cash Flow: -63137 Open source Capital Expenditure: 0 Open source
20092009-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -63.1K 2003

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20012001-12-31	Operating cash flow	-109930	Operating Cash Flow: -109930 Open source
20022002-12-31	Operating cash flow	-483294	Operating Cash Flow: -483294 Open source
20032003-12-31	Operating cash flow	-63137	Operating Cash Flow: -63137 Open source
20092009-12-31	Operating cash flow	Not reported	No source recorded

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -63.1K 2003

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20012001-12-31	Free cash flow	-119132	Operating Cash Flow: -109930 Open source Capital Expenditure: 9202 Open source
20022002-12-31	Free cash flow	-510762	Operating Cash Flow: -483294 Open source Capital Expenditure: 27468 Open source
20032003-12-31	Free cash flow	-63137	Operating Cash Flow: -63137 Open source Capital Expenditure: 0 Open source
20092009-12-31	Free cash flow	Unavailable	No source recorded

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

11,345.2% 2003

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20012001-12-31	Liabilities / assets	176.5%	Total Liabilities: 998806 Open source Total Assets: 565797 Open source
20022002-12-31	Liabilities / assets	2,233%	Total Liabilities: 1028492 Open source Total Assets: 46058 Open source
20032003-12-31	Liabilities / assets	11,345.2%	Total Liabilities: 600500 Open source Total Assets: 5293 Open source
2009-12-31	Liabilities / assets	Not reported	No source recorded

Current assets to current liabilities

Current assets divided by current liabilities.

0.01× 2003

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20012001-12-31	Current assets / current liabilities	0.08×	Current Assets: 67255 Open source Current Liabilities: 848806 Open source
20022002-12-31	Current assets / current liabilities	Not reported	Current Assets: 9280 Open source
20032003-12-31	Current assets / current liabilities	0.01×	Current Assets: 5143 Open source Current Liabilities: 602324 Open source
2009-12-31	Current assets / current liabilities	Not reported	No source recorded

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2001 2001-01-01 – 2001-12-31	−USD 753,663 Exact value Exact value: -753663 USD 2001-01-01 – 2001-12-31: -753663 USD Inspect Net Income Open source Share or cite Citation for Net Income · Immunotech Laboratories, Inc. · 2001-12-31 Immunotech Laboratories, Inc. (edgar:1137117) Net Income: -753663 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T21:37:50Z Snapshot: ff1d4b481ef343d8710d3bed65d25da7f5b793da7310b08d8febdc5386509a2b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1137117/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -753663 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1137117/0001017386-03-000111.txt#1067 The citation records this snapshot. The page link may show a newer release later.	−USD 109,930 Exact value Exact value: -109930 USD 2001-01-01 – 2001-12-31: -109930 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Immunotech Laboratories, Inc. · 2001-12-31 Immunotech Laboratories, Inc. (edgar:1137117) Operating Cash Flow: -109930 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T21:37:50Z Snapshot: ff1d4b481ef343d8710d3bed65d25da7f5b793da7310b08d8febdc5386509a2b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1137117/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -109930 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1137117/0001017386-03-000111.txt#1077 The citation records this snapshot. The page link may show a newer release later.	USD 9,202 Exact value Exact value: 9202 USD 2001-01-01 – 2001-12-31: 9202 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Immunotech Laboratories, Inc. · 2001-12-31 Immunotech Laboratories, Inc. (edgar:1137117) Capital Expenditure: 9202 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T21:37:50Z Snapshot: ff1d4b481ef343d8710d3bed65d25da7f5b793da7310b08d8febdc5386509a2b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1137117/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 9202 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1137117/0001017386-03-000111.txt#1087 The citation records this snapshot. The page link may show a newer release later.	−USD 119,132 Calculation and evidence -109930 − 9202 USD Exact free cash flow: -119132 USD 2001-01-01 – 2001-12-31: -109930 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 9202 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Immunotech Laboratories, Inc. · 2001-12-31 Immunotech Laboratories, Inc. (edgar:1137117) Free cash flow: -119132 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T21:37:50Z Snapshot: ff1d4b481ef343d8710d3bed65d25da7f5b793da7310b08d8febdc5386509a2b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1137117?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -109930 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1137117/0001017386-03-000111.txt#1077 Input fundies:CapitalExpenditure: 9202 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1137117/0001017386-03-000111.txt#1087 The citation records this snapshot. The page link may show a newer release later.
2002 2002-01-01 – 2002-12-31	−USD 1.55 million Exact value Exact value: -1545125 USD 2002-01-01 – 2002-12-31: -1545125 USD Inspect Net Income Open source Share or cite Citation for Net Income · Immunotech Laboratories, Inc. · 2002-12-31 Immunotech Laboratories, Inc. (edgar:1137117) Net Income: -1545125 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T21:37:50Z Snapshot: ff1d4b481ef343d8710d3bed65d25da7f5b793da7310b08d8febdc5386509a2b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1137117/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1545125 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1137117/0001170423-05-000050.txt#957 The citation records this snapshot. The page link may show a newer release later.	−USD 483,294 Exact value Exact value: -483294 USD 2002-01-01 – 2002-12-31: -483294 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Immunotech Laboratories, Inc. · 2002-12-31 Immunotech Laboratories, Inc. (edgar:1137117) Operating Cash Flow: -483294 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T21:37:50Z Snapshot: ff1d4b481ef343d8710d3bed65d25da7f5b793da7310b08d8febdc5386509a2b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1137117/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -483294 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1137117/0001108890-04-000263.txt#977 The citation records this snapshot. The page link may show a newer release later.	USD 27,468 Exact value Exact value: 27468 USD 2002-01-01 – 2002-12-31: 27468 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Immunotech Laboratories, Inc. · 2002-12-31 Immunotech Laboratories, Inc. (edgar:1137117) Capital Expenditure: 27468 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T21:37:50Z Snapshot: ff1d4b481ef343d8710d3bed65d25da7f5b793da7310b08d8febdc5386509a2b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1137117/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 27468 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1137117/0001170423-05-000050.txt#977 The citation records this snapshot. The page link may show a newer release later.	−USD 510,762 Calculation and evidence -483294 − 27468 USD Exact free cash flow: -510762 USD 2002-01-01 – 2002-12-31: -483294 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 27468 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Immunotech Laboratories, Inc. · 2002-12-31 Immunotech Laboratories, Inc. (edgar:1137117) Free cash flow: -510762 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T21:37:50Z Snapshot: ff1d4b481ef343d8710d3bed65d25da7f5b793da7310b08d8febdc5386509a2b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1137117?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -483294 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1137117/0001108890-04-000263.txt#977 Input fundies:CapitalExpenditure: 27468 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1137117/0001170423-05-000050.txt#977 The citation records this snapshot. The page link may show a newer release later.
2003 2003-01-01 – 2003-12-31	−USD 314,597 Exact value Exact value: -314597 USD 2003-01-01 – 2003-12-31: -314597 USD Inspect Net Income Open source Share or cite Citation for Net Income · Immunotech Laboratories, Inc. · 2003-12-31 Immunotech Laboratories, Inc. (edgar:1137117) Net Income: -314597 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T21:37:50Z Snapshot: ff1d4b481ef343d8710d3bed65d25da7f5b793da7310b08d8febdc5386509a2b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1137117/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -314597 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1137117/0001170423-05-000050.txt#957 The citation records this snapshot. The page link may show a newer release later.	−USD 63,137 Exact value Exact value: -63137 USD 2003-01-01 – 2003-12-31: -63137 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Immunotech Laboratories, Inc. · 2003-12-31 Immunotech Laboratories, Inc. (edgar:1137117) Operating Cash Flow: -63137 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T21:37:50Z Snapshot: ff1d4b481ef343d8710d3bed65d25da7f5b793da7310b08d8febdc5386509a2b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1137117/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -63137 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1137117/0001108890-04-000263.txt#977 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2003-01-01 – 2003-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Immunotech Laboratories, Inc. · 2003-12-31 Immunotech Laboratories, Inc. (edgar:1137117) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T21:37:50Z Snapshot: ff1d4b481ef343d8710d3bed65d25da7f5b793da7310b08d8febdc5386509a2b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1137117/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1137117/0001170423-05-000050.txt#977 The citation records this snapshot. The page link may show a newer release later.	−USD 63,137 Calculation and evidence -63137 − 0 USD Exact free cash flow: -63137 USD 2003-01-01 – 2003-12-31: -63137 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Immunotech Laboratories, Inc. · 2003-12-31 Immunotech Laboratories, Inc. (edgar:1137117) Free cash flow: -63137 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T21:37:50Z Snapshot: ff1d4b481ef343d8710d3bed65d25da7f5b793da7310b08d8febdc5386509a2b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1137117?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -63137 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1137117/0001108890-04-000263.txt#977 Input fundies:CapitalExpenditure: 0 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1137117/0001170423-05-000050.txt#977 The citation records this snapshot. The page link may show a newer release later.
2009 2009-01-01 – 2009-12-31	−USD 977,570 Exact value Exact value: -977570 USD 2009-01-01 – 2009-12-31: -977570 USD Inspect Net Income Open source Share or cite Citation for Net Income · Immunotech Laboratories, Inc. · 2009-12-31 Immunotech Laboratories, Inc. (edgar:1137117) Net Income: -977570 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T21:37:50Z Snapshot: ff1d4b481ef343d8710d3bed65d25da7f5b793da7310b08d8febdc5386509a2b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1137117/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -977570 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1137117/0001017386-11-000003.txt#2382 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

34 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001137117, 1137117, edgar:1137117

Also known as EARTHNETMEDIA INC, INTERNATIONAL TELECOMMUNICATION, INC., INTERNATIONAL TELECOMMUNICATIONS, INC., International Technology Systems, Inc.

Immunotech Laboratories, Inc.

Latest quarter

Revenue

Trailing twelve months

Capital expenditure

Company performance

What changed year over year

Where revenue goes

2009 2009-01-01 – 2009-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation